Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Quantifying uptake And Real-world impact of Diabetes Treatments

Project description

Assessing real-world impact of advanced diabetes treatments

Diabetes affects over 10 % of adults. Despite advances in treatment, there is a need for global leadership in equitable diabetes health services and policy development. Supported by the Marie Skłodowska-Curie Actions programme, the QUART-DT project will assess the real-world effectiveness and fairness of advanced diabetes treatments across Japan, Ireland and the UK. It will evaluate the gap between clinical trials and everyday use, known as the ‘voltage drop’, and introduce an equitable scale-up index for fair access. Using various methods, the project will estimate health impacts and deliver outputs including open protocols and dashboards for policymakers. The fellowship will offer training in advanced pharmacoepidemiology and equity methods, focusing on societal benefits.

Objective

Diabetes affects >10% of adults QUART-DT (QUantifying uptake And Real-world impacT of Diabetes Treatments) will quantify real-world coverage and fairness of advanced diabetes treatments, including sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and sensor-augmented insulin pump therapy, measure the gap between randomized controlled trials and effectiveness in routine care (“voltage drop”), and model population health impact across Japan, Ireland, and the United Kingdom using harmonised health data.
We will introduce two decision-ready indicators: an equitable scale-up index that summarises fair access, and a voltage-drop measure that compares matched effects from trials and real-world studies. The work will use the concentration index with the Erreygers correction for equity analysis, target-trial emulation with new-user, active-comparator designs, and state-transition modelling to estimate disability-adjusted life years and prevented events. Outputs will include open protocols, reusable analysis code, and concise dashboards and policy briefs for guideline developers and payers.
Training: The fellowship provides practical training in advanced pharmacoepidemiology (target-trial emulation and robustness diagnostics), equity methods, population-impact modelling, and natural-experiment designs, alongside transferable skills in research integrity, data governance and protection, communication, and project and budget management, structured through a career development plan.
Alignment and career objective: The project is international, interdisciplinary, and intersectoral, integrates open science and public and patient involvement, and targets societal benefit by showing who benefits, by how much, and under what delivery conditions. The fellowship will prepare the researcher to lead equity-focused diabetes health services and policy research and to contribute to data-driven guideline and policy development in Japan and internationally.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

ROYAL COLLEGE OF SURGEONS IN IRELAND
Net EU contribution
€ 268 568,64
Address
ST STEPHEN GREER 123
D02 YN77 DUBLIN 2
Ireland
Region
Ireland Eastern and Midland Dublin
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data